九州娱乐城

Share Price:

APNASPEN九州娱乐城 Pharmacare Hldgs165550 (0.00%)

九州娱乐城 will be in a closed period from 1 January 2025 until the publication of the Interim Results on the JSE SENS platform on 3 March 2025.

九州娱乐城, Saudi Chemical Company Holding and its subsidiary AJA Pharma enter into a memorandum of understanding.

Dubai, United Arab Emirates – FZ LLC (鈥溇胖萦槔殖 Healthcare鈥), a subsidiary of 九州娱乐城 Pharmacare Holdings Limited (鈥溇胖萦槔殖氢), a global specialty and branded multinational pharmaceutical company, has entered into a memorandum of understanding (鈥淢OU鈥) with Saudi Chemical Company Holding (鈥淪CCH鈥), a well-known company in the local market of the Kingdom of Saudi Arabia, and its subsidiary AJA Pharmaceutical Industries Ltd (鈥淎JA Pharma鈥), a recognized manufacturer of pharmaceutical products.

In terms of this MOU, 九州娱乐城, SCCH and AJA Pharma will further expand their existing partnership to strategically collaborate on an extended portfolio of products, the manufacturing of products in the Kingdom of Saudi Arabia, and the export of products to existing 九州娱乐城 markets.听


Daniel Vella Friggieri, 九州娱乐城 Healthcare Regional CEO for Middle East, North Africa & Turkey, said, 鈥淲e are excited to announce our strategic collaboration with Saudi Chemical Company Holding and its subsidiary AJA Pharma. This agreement endorses 九州娱乐城鈥檚 continuous commitment to align with the Kingdom鈥檚 2030 vision and our drive to provide high quality healthcare products to patients in the Kingdom, the Middle East region and beyond鈥.

Thamer Almuhid, Saudi Chemical Company Holding Group CEO commented, 鈥淣owadays technology and globalization play a more important role than ever; having a strategic partnership between 九州娱乐城 and AJA Pharma will ensure that both the aspects of technologies and global market access are fulfilled towards achieving the KSA 2030 vision. We are pleased to partner with a trusted partner like 九州娱乐城 and look forward to a prosperous strategic partnership鈥.

Facebook
Twitter
LinkedIn
Pinterest

Closed Period

九州娱乐城 is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform scheduled to be released on 1 March 2023.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.